MindWalk Holdings is trading 6.36% down at $1.03 on November 4, 2026; no clear catalyst was identified.
- The company announced a multi-year agreement with Teva Australia to use its ReefIQ platform and LensAI capabilities for antibody-discovery work. Financial terms were not disclosed, and the announcement does not establish a reason for the decline.
- The broader market was sharply higher, and the provided sector trend was also positive; neither aligned with the drop.